| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Jun―14 |
The effectiveness of antihypoxic and cardioprotective drug in the rehabilitation of patients with COVID-19 associated pneumonia |
S Bondarev, I Stulikova, M Nasrulaev |
| 2 |
[GO] |
2024―Jun―14 |
Exploring predictors and correlations of COVID-19 impact in revascularized patients |
O Musayev, R Dashdemirov, F Ibrahimov, K Musayev, Z Alimli, M Gafarova, N Mushtagzadeh |
| 3 |
[GO] |
2024―Jun―14 |
Association of education and non-partnered relationship with all-cause and cardiovascular mortality before and during the COVID-19 pandemic in a prospective population-based cohort study |
M Bobak, A Bartoskova Polcrova, H Pikhart |
| 4 |
[GO] |
2024―Jun―14 |
microRNA profile of inflammatory response in COVID-19 participants |
S L Russell, C Lozahic, M Rahman, N Okwose, S M Raleigh, G Mcgregor, et al. (+4) H Maddock, P Banerjee, D G Jakovljevic, H Sandhu |
| 5 |
[GO] |
2024―Jun―14 |
Increased incidence of arrhythmias, heart failure and thrombosis in COVID-19 patients after the first 3 months post-infection: a population-based cohort study |
I R Degano, C Tintore, A Camps-Vilaro, I Subirana, R Elosua, J Marrugat |
| 6 |
[GO] |
2024―Jun―14 |
Association of cardiorespiratory fitness measured by cardiopulmonary exercise testing with covid-19 positivity: a prospective register-based cohort study |
E A E Espen Alexander Eriksen, D S Dorthe Stensvold, J N Javaid Nauman, U W Ulrik Wisloeff, T O Torbjoern Omland |
| 7 |
[GO] |
2024―Jun―14 |
The impact of cardiorespiratory fitness on COVID-19 related outcomes: the ETHOS Study |
J Myers, P Kokkinos, C Cadenas-Sanchez, A Liappis, N Goraya, A Weintrob, et al. (+4) A Pittaras, A Ladas, M Heimall, C Faselis |
| 8 |
[GO] |
2024―Jun―14 |
Pro-inflammatory cytokines are elevated two-years after acute severe COVID-19: a pre-vaccine, two-years, five-point longitudinal assessment of individuals with Long COVID |
C Luz Goulart, A B S M Alex Bezerra Da Silva Maciel, A G R Anna Gabriela Rezende, J V Jefferson Valente, B M S Bernardo Maia Da Silva, V S Vanderson Sampaio, et al. (+3) A G Allyson Guimaraes, G P T A Guilherme Peixoto Tinoco Areas, F F A V Fernando Fonseca De Almeida E Val |
| 9 |
[GO] |
2024―Jun―14 |
Muscle oxygenation kinetics in Long COVID-19: Illness severity and clinical implications |
C Luz Goulart, R F B Robson Fernando Borgesa, C C C H S Claudia Cristina Conde Holanda Sobral, T B Thomas Beltrame, M M Mauricio Milani, G C J Gerson Cipriano Junior, et al. (+4) A C P S Ana Cleides Pereira Dos Santos, R S Ricardo Stein, F B Fabricio Braga, L E F R Luiz Eduardo Fonteles Ritt |
| 10 |
[GO] |
2024―Jun―14 |
Higher inflammatory cytokines in long-covid with cardiovascular symptoms after acute severe COVID-19? A two-year, pre-vaccine, longitudinal, exploratory, nested cohort |
F Fonseca De Almeida E Val, C L G Cassia Da Luz Goulart, A B S M Alex Bezerra Da Silva Maciel, J V Jefferson Valente, V S Vanderson Sampaio, A G Allyson Guimaraes, G P T A Guilherme Peixoto Tinoco Areas |
| 11 |
[GO] |
2024―Jun―14 |
Genetic variants associated with cardiorespiratory symptoms of long COVID. The GINA-COVID study |
S Polo-Alonso, A Camps-Vilaro, I R Degano, R Marti-Lluch, M Pinsach-Abuin, E Selga, et al. (+9) E Puigdecanet, M Pedrerol-Alvarez, M Puigmule, A Perez, I Subirana, R Elosua, R Brugada, R Ramos, J Marrugat |
| 12 |
[GO] |
2024―Jun―14 |
Daily-life and work activities are more impaired in individuals with long covid who present cardiopulmonary symptoms: preliminary results from a cross-sectional assessment |
F Fonseca De Almeida E Val, C L G Cassia Da Luz Goulart, J V Jefferson Valente, A G R Anna Gabriela Rezende, B M S Bernardo Maia Da Silva, A V N Alexandre Vilhena Neto, G P T A Guilherme Peixoto Tinoco Areas |
| 13 |
[GO] |
2024―Jun―14 |
Dysfunctional breathing in long COVID: inter-rater agreement and clinical characteristics |
M Milani, J S Neiva, A D Silveira, J G P O Milani, G Cipriano Junior, G F B Cipriano |
| 14 |
[GO] |
2024―Mar―04 |
Behind the shadows: Bringing the cardiovascular secrets of long COVID into light |
Joseph Adu-Amankwaah |
| 15 |
[GO] |
2024―Feb―20 |
Cardiovascular disease as part of Long COVID: A systematic review |
Vasiliki Tsampasian, Maria Bäck, Marco Bernardi, Elena Cavarretta, Maciej Dębski, Sabiha Gati, et al. (+8) Dominique Hansen, Nicolle Kränkel, Konstantinos Koskinas, Josef Niebauer, Luigi Spadafora, Manuel Frias Vargas, Giuseppe Biondi-Zoccai, Vassilios S Vassiliou |
| 16 |
[GO] |
2024―Jan―20 |
Cardiopulmonary limitations in young Long Covid patients: A case control study |
Geza Halasz, Francesco Di Spigno, Davide Donelli, Alessandro Giacani, Luca Moderato, Davide Lazzeroni, et al. (+2) Leonardo De Luca, Massimo Piepoli |
| 17 |
[GO] |
2023―Dec―14 |
Correction to: Vaccines and variants: an update on cardiopulmonary assessment prior to return to high-hazard occupations following COVID-19 |
|
| 18 |
[GO] |
2023―May―24 |
Enlarged dimensions of cardiac chambers and the root of the aorta as a significant cardiovascular impact of pandemic COVID-19: a population-based study |
M Chlabicz, M Dubatowka, J Jamiolkowski, A Szum-Jakubowska, S Solomacha, N Zieleniewska, et al. (+6) P Sowa, S Lawicki, A Szpakowicz, K Ptaszynska-Kopczynska, A M Moniuszko-Malinowska, K A Kaminski |
| 19 |
[GO] |
2023―May―24 |
Telemonitoring of patients after COVID-19 hospitalization: study design and baseline characteristics |
M Hiddemann, K Koehler, L Riehle, S Prescher, C Butter, R Prondzinsky, et al. (+4) S Winkler, V Moeller, S Spethmann, F Koehler |
| 20 |
[GO] |
2023―May―24 |
Impact of COVID-19 situation on non COVID myocardial infarction admissions |
H Del Castillo-Carnevali, J Alvarez, J Torres, S Magnani, M E Morante, A Sahuquillo, et al. (+3) T Ripoll, V Peral, J M Gamez |
| 21 |
[GO] |
2023―May―24 |
Impact of COVID-19 situation on non COVID cardiological admissions |
H Del Castillo-Carnevali, J Alvarez, T O R R E S Joan, S Magnani, D Cremer, V Ruiz, et al. (+5) M Alamar, M E Moranta, P Folgado, T Ripoll, J M Gamez |
| 22 |
[GO] |
2023―May―24 |
Variation in complexity weight values for heart failure admissions: the impact of COVID-19 situation |
H Del Castillo-Carnevali, A Sahuquillo, T Ripoll, J Torres, J Alvarez, D Cremer, et al. (+2) B Coto, J M Gamez |
| 23 |
[GO] |
2023―May―24 |
The impact of COVID-19 pandemic on cardiovascular diseases hospitalization, management and mortality in Switzerland |
K Maung, P Marques-Vidal |
| 24 |
[GO] |
2023―May―24 |
Determinants of Hospitalisation and Intubation in COVID-19 Infection |
R A Xuereb, J Gatt, J Barbara, N Tabone Adami, J Darmanin, R Erasmi, et al. (+4) R G Xuereb, C Barbara, S Fava, C J Magri |
| 25 |
[GO] |
2023―May―24 |
The impact of the COVID-19 pandemic on the quality of centre-based cardiac rehabilitation |
B Jug, J Trsan, M Novakovic, J Tasic, B Krevel, Z Fras, et al. (+2) M Lainscak, J Farkas Lainscak |
| 26 |
[GO] |
2023―May―24 |
Prevalence and diagnostic significance of de-novo 12-lead electrocardiogram patterns following covid-19 infection in elite soccer players |
R Bhatia, A Malhotra, H Maclachlan, S Gati, S Marwaha, N Chatrath, et al. (+9) S Fyyaz, R Cooper, J Daems, J Hattum, G Finocchiaro, R Stein, H Jorstad, M Papadakis, S Sharma |
| 27 |
[GO] |
2023―May―24 |
Prevalence of abnormal cardiovascular magnetic resonance findings in athletes recovered from COVID-19 |
V Tsampasian, R W Catumbela, E Androulakis, S Gati, M Papadakis, V S Vassiliou |
| 28 |
[GO] |
2023―May―24 |
Analysis of long-term cardiovascular outcomes of COVID-19. Artificial Intelligence model for risk evaluation |
A Hovornyan, T O Ilashchuk |
| 29 |
[GO] |
2023―May―24 |
Traditional media or chatbot: how can we reach older adults with the COVID-19 information they need? |
R Olszewski, K Cwiklinska, J Brzezinski, J Owoc, M Manczak, M Zaremba, et al. (+2) T Targowski, K Jeziorski |
| 30 |
[GO] |
2023―May―24 |
Association of right and left atrial strain with laboratory, anthropometric and echocardiographic markers - the influence of COVID-19 pandemic |
M Dubatowka, M Chlabicz, P Sowa, J Jamiolkowski, S Solomacha, N Zieleniewska, et al. (+3) M Lapinska, A M Moniuszko-Malinowska, K A Kaminski |
| 31 |
[GO] |
2023―May―24 |
The role of tele-rehabilitation in post-myocardial infarction populations during the covid-19 pandemic in a tertiary care centre |
K K K Kyaw |
| 32 |
[GO] |
2023―May―24 |
Alteration of circulating ACE2-network related miRNAs in patients with COVID-19 |
Z Wicik, C Eyileten, A Nowak, D Keshwani, S N Simoes, D C Martins Jr, et al. (+7) K Klos, W Wlodarczyk, A Assinger, D Soldacki, A Chcialowski, J Siller-Matula, M Postula |
| 33 |
[GO] |
2023―May―24 |
Impact of telemedicine on treatment of diabetes mellites in patients with cardiovascular Disease during SARS-Cov-2 pandemic |
R Nakauchi, N Nishio, N Nishio, Y Fujii, Y Fujii, A Takahashi, et al. (+6) A Takahashi, T Yamada, N Taniguchi, T Hata, S Nakajima, Y Takahashi |
| 34 |
[GO] |
2023―May―24 |
Effect of a home-based inspiratory muscle training program on functional capacity in post-discharged patients with long COVID: The InsCOVID trial |
C Albiach, E Dominguez, L Lopez, C Sastre, S Minguez, J Nunez, P Palau Sampio |
| 35 |
[GO] |
2022―Oct―16 |
Return to play after COVID-19 infection in child and adolescent athletes: Should Physician’s clearance always be required? |
Luis Serratosa |
| 36 |
[GO] |
2022―Oct―06 |
Vaccines and Variants: An update on cardiopulmonary assessment prior to return to high-hazard occupations following COVID-19 |
Oliver O’Sullivan, Rienk Rienks, David Holdsworth, Constantinos H Davos, Martin Halle, Alexander Bennett, et al. (+3) Gianfranco Parati, Norbert Guettler, Edward Nicol |
| 37 |
[GO] |
2022―Oct―06 |
Immune response after mRNA COVID-19 vaccination in heart transplant recipients: long-term follow-up and evaluation of a third vaccination |
Selma Tobudic, Keziban Uyanik-Ünal, Maximilian Koblischke, Lisa Schneider, Stephan Blüml, Florian Winkler, et al. (+5) Helmuth Haslacher, Thomas Perkmann, Heinz Burgmann, Judith H Aberle, Stefan Winkler |
| 38 |
[GO] |
2022―Jul―07 |
The effect of smoking on exhaled carbon monoxide and arterial elasticity during prolonged surgical mask use in the COVID-19 era |
Ignatios Ikonomidis, Konstantinos Katogiannis, Kallirhoe Kourea, Kostelli Gavriella, Damianos Tsilivarakis, Vaia Lambadiari, et al. (+2) Dimitrios Kouretas, Giuseppe Biondi-Zoccai |
| 39 |
[GO] |
2022―Jun―16 |
Impact of COVID-19 on young healthcare professionals |
Martin Bahls, Marwa H Gaber, Harald T Jorstad, Najat Mouine, Martijn Scherrenberg, Elena Marques-Sule |
| 40 |
[GO] |
2022―May―11 |
Physical activity and psychological status of hypertensive and healthy individuals: in the era of COVID-19 |
B Karaduz, YZ Sener, N Vardar Yagli, E Calik Kutukcu, L Tokgozoglu |
| 41 |
[GO] |
2022―May―11 |
Cardiac Rehabilitation during COVID-19 |
C Desira, G De Gray, J Fleri Soler, M Abela |
| 42 |
[GO] |
2022―May―11 |
Covid-19 and ischemic heart disease: clinical manifestations, biomarkers, treatment and follow-up |
V Tashchuk, R Nesterovska |
| 43 |
[GO] |
2022―May―11 |
Low prevalence of cardiac abnormalities in competitive athletes before the return-to-play after COVID-19 based on the italian strategy |
M Penza, D Filomena, L Birtolo, S Monosilio, A Serdoz, R Fiore, et al. (+9) R Mango, E Lemme, M Squeo, F Fedele, G Gualdi, A Spataro, A Pelliccia, B Di Giacinto, V Maestrini |
| 44 |
[GO] |
2022―May―11 |
Nutrition guidelines compliance in cardiovascular disease patients attending a long-term exercise-based cardiac rehabilitation program during COVID-19 era |
M Linan Pinto, S Charneca, J Vasques, R Pinto, M Lemos Pires, M Borges, et al. (+3) H Santa-Clara, A Abreu, C Sousa Guerreiro |
| 45 |
[GO] |
2022―May―11 |
Cardiorespiratory fitness assessment on active patients who kept attending their phase III exercise-based cardiac rehabilitation during the COVID-19 era |
J Lopes, R Pinto, M Borges, M Pires, A Nunes, J Brito, et al. (+4) P Silva, I Ricardo, F Pinto, A Abreu |
| 46 |
[GO] |
2022―May―11 |
Cardiovascular disease after COVID-19 infection in elderly patients. Results of annual follow-up of a cohort of survivors |
D Aguila Gordo, J Piqueras Flores, J Martinez Del Rio, M Negreira Caamano, C Mateo Gomez, M Soto Perez, et al. (+7) AF Cubides Novoa, A Moron Alguacil, M Munoz Garcia, E Blanco Lopez, P Soto Martin, D Salas Bravo, JM Arizon Munoz |
| 47 |
[GO] |
2022―May―11 |
Impact of COVID-19 infection on a physically active population: evaluation functional using the Cardiopulmonar Exercise Test (CPET) |
A Berenguel Senen, J Borrego Rodriguez, JR Godoy Lopez, A Gadella Fernandez, C De Cabo Porras, A Serrano Blanco, et al. (+8) M Gallango Brejano, E Gigante Miravalles, MC Morante Perea, PL Cepas-Guillen, M Lazaro Salvador, ME Villasante Felix, F Fernandez-Vazquez, L Rodriguez Padial |
| 48 |
[GO] |
2022―May―11 |
Unhealthy behaviours of patients with cardiovascular diseases during the second COVID-19 lockdown in Northern Greece |
A Ioannidis, A Pechlevanis, M Paraskelidou, A Fragkiskou, V Giakoumi, D Lakias |
| 49 |
[GO] |
2022―May―11 |
Extend of unhealthy behaviours of patients with cardiovascular diseases during the second COVID-19 lockdown in Northern Greece: comparison between urban and rural residents |
A Ioannidis, A Fragkiskou, A Pechlevanis, M Paraskelidou, V Giakoumi, F Asmani |
| 50 |
[GO] |
2022―May―11 |
COVID-19 pandemia impact on patients included in heart rehabilitation programme |
B Coto Morales, EM Basabe Velasco, IM Gomez Sanchez, D Marti Sanchez, AF Marschall, FA Delgado Calva, et al. (+9) HA Del Castillo Carnevalli, DJ Rodriguez Torres, MF Rodriguez Biezma, A Molinos, MA Rodriguez Gamero, MP Casanova Lopez, J Fuentes Pereiro, MA Sastre Perona, SA Alvarez Anton |
| 51 |
[GO] |
2022―May―11 |
Impact of a home-based cardiac rehabilitation program in heart failure during the COVID-19 pandemic |
C Schmidt, PG Basilio, S Magalhaes, A Alexandre, A Barreira, P Fernandes, et al. (+2) F Ribeiro, M Santos |
| 52 |
[GO] |
2022―May―11 |
A retrospective observational study of face-to-face versus hybrid phase II cardiac rehabilitation program during COVID-19 pandemic |
N Santaularia, A Arnau, N Tora, A Ramirez-Morros, G Vazquez-Oliva |
| 53 |
[GO] |
2022―May―11 |
Implementing hybrid telerehabilitation following major cardiac surgery during COVID-19 pandemic in Hong Kong |
K F Wong, N Fu, KYY Fan, K Y Cheng, K L Wong, C Y Yung, et al. (+2) C K L Ho, TWK Au |
| 54 |
[GO] |
2022―May―11 |
Acute coronary syndromes hospitalizations and in-hospital outcomes during and after the lockdown of corona virus disease 19 (COVID-19) pandemic outbreak |
L Simoni, I Alimehmeti, M Gina, A Ceka, E Tafaj, A Voci, et al. (+4) A Panariti, F Xhafa, A Dibra, A Goda |
| 55 |
[GO] |
2022―May―11 |
Virtual cardiac rehabilitation during the COVID-19 pandemic: a tertiary site experience |
N Moulson, J Robinson, S Chan, D Cuff, A Ignaszewski, S Isserow, et al. (+5) B Lau, N Ordano, L Sung, J Werry, C Taylor |
| 56 |
[GO] |
2022―May―11 |
Cardiac practice during the second year of COVID-19 pandemic: are we going back to normal? |
Z A Dakhil, F A Cader, TUG˘BA Oz, NUNZIA Borreli |
| 57 |
[GO] |
2022―May―11 |
Echocardiographic findings in COVID-19 patients with cardiovascular disease |
G Smyrnova, T Babkina |
| 58 |
[GO] |
2022―May―11 |
COVID-19 survivors are physically inactive with high levels of sedentary time, regardless of patient characteristics, disease severity or cardiac dysfunction |
BMA Van Bakel, FMA Van Den Heuvel, JL Vos, H Rotbi, EA Bakker, R Nijveldt, et al. (+2) DHJ Thijssen, TMH Eijsvogels |
| 59 |
[GO] |
2022―May―11 |
Covid-19 survivors may have deterioration in frontal plane qrs-t angle and the other electrocardiogram parameters |
M S Kuyumcu, S Ulusan |
| 60 |
[GO] |
2022―May―11 |
Relationship between the spread of coronavirus disease 2019, social frailty and depressive symptoms in patients with heart failure |
S Shakuta, M Yamashita, K Kamiya, N Hamazaki, K Nozaki, S Uchida, et al. (+6) T Noda, K Ueno, E Maekawa, M Yamaoka-Tojo, A Matsunaga, J Ako |
| 61 |
[GO] |
2022―May―11 |
Coronavirus-related stress, anxiety, and obsessive thinking in patients undergoing cardiac rehabilitation during the COVID19 pandemic |
B Jug, J Farkas Lainscak, N Sedlar, D Stojnic, M Lainscak |
| 62 |
[GO] |
2022―May―11 |
SARS-CoV-2 associated cardiac abnormalities in elite athletes: results from the prospective, longitudinal COMMIT cohort |
J Van Hattum, SM Verwijs, SE Davelaar, JJN Daems, SM Boekholdt, M Groenink, et al. (+9) RN Planken, RD Van Luijk-Snoeks, AM Van Den Berg-Faay, MH Moen, CACM Wijne, AJ Nederveen, YM Pinto, AAM Wilde, HT Jorstad |
| 63 |
[GO] |
2022―May―11 |
Cardiovascular screening in olympic athletes before and after SARS-CoV-2 infection |
V Maestrini, D Filomena, L I Birtolo, S Monosilio, M Tatangelo, M Penza, et al. (+9) A Serdoz, R Fiore, E Lemme, M R Squeo, F Fedele, G Gualdi, A Spataro, A Pelliccia, B Di Giacinto |
| 64 |
[GO] |
2022―May―11 |
SARS-CoV-2 infection and return-to-play in junior competitive athletes: is systematic cardiac screening needed? |
L Cavigli, M Cillis, V Mochi, F Frascaro, N Mochi, A Hajdarevic, et al. (+9) A Roselli, M Capitani, F Alvino, C Lisi, GE Mandoli, S Valente, M Focardi, M Cameli, F D'ascenzi |
| 65 |
[GO] |
2022―May―11 |
Changes in antihypertensive treatment in surviving patients SARS-CoV-2 respiratory infection and its cardiovascular impact after one year of follow-up |
D Aguila Gordo, J Martinez Del Rio, J Piqueras Flores, M Negreira Caamano, C Mateo Gomez, M Soto Perez, et al. (+7) D Salas Bravo, JM Arizon Munoz, AF Cubides Novoa, M Munoz Garcia, E Blanco Lopez, P Soto Martin, A Moron Alguacil |
| 66 |
[GO] |
2022―May―11 |
Genetic risk score for risk stratification of patients positive for SARS-CoV-2 virus. The CARGENCORS study |
A Camps-Vilaro, I R Degano, R Brugada, R Elosua, R Ramos, R Marti, et al. (+9) I Subirana, X Nogues, JR Masclans, R Guerri, J Marin, H Tizon, B Vaquerizo, M Pinsach, J Marrugat |
| 67 |
[GO] |
2022―May―11 |
Physical and psychological reconditioning in long covid syndrome patients: results of a structured physical exercise program |
S Palermi, S Compagno, V Pescatore, E Brugin, G Tegon, M Sarto, et al. (+7) R Marin, V Calzavara, M Nizzetto, M Scevola, C Albertin, A Biffi, F Giada |
| 68 |
[GO] |
2022―Feb―21 |
Exercise-induced Cardiac Troponin T Release in Veteran Athletes Recovered from COVID-19 |
Sylvan L J E Janssen, Vincent L Aengevaeren, Coen C W G Bongers, Geert Kleinnibbelink, Femke de Vries, Alma M A Mingels, et al. (+2) Thijs M H Eijsvogels, Maria T E Hopman |
| 69 |
[GO] |
2022―Jan―24 |
Effects of exercise rehabilitation in patients with long COVID-19 |
Cristina Barbara, Piero Clavario, Vincenzo De Marzo, Roberta Lotti, Giulia Guglielmi, Annalisa Porcile, et al. (+5) Carmelo Russo, Raffaele Griffo, Timo Mäkikallio, Arto Jorma Hautala, Italo Porto |
| 70 |
[GO] |
2022―Jan―03 |
Letter on Incidence and prognosis of COVID-19 amongst heart transplant recipients: a systematic review and meta-analysis |
Saeed Shoar |
| 71 |
[GO] |
2022―Jan―03 |
COVID-19 in heart transplant patients: is there a cause for concern? |
Huzaifa Ahmad Cheema, Abia Shahid |
| 72 |
[GO] |
2021―Sep―01 |
COVID-19 pandemic and cardiovascular disease: the double sentence |
Julien Vaucher |
| 73 |
[GO] |
2021―Jun―30 |
Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19 |
Benjamin J R Buckley, Stephanie L Harrison, Elnara Fazio-Eynullayeva, Paula Underhill, Ian D Jones, Nefyn Williams, Gregory Y H Lip |
| 74 |
[GO] |
2021―May―11 |
Blood pressure level and laboratory indicators of disease severity in patients with arterial hypertension and COVID-19 |
K Popov, A Novitskiy, Y Shvarts |
| 75 |
[GO] |
2021―May―11 |
COVID-19 era in long-term cardiac rehabilitation programs: how did physical activity and sedentary time change compared to previous years? |
M Lemos Pires, M Borges, R Pinto, I Ricardo, N Cunha, P Alves Da Silva, et al. (+5) M Linan Pinto, C Sousa Guerreiro, FJ Pinto, H Santa-Clara, A Abreu |
| 76 |
[GO] |
2021―May―11 |
COVID-19 era in long-term cardiac rehabilitation programs: how was muscle strenght and lean mass affected in cardiovascular patients? |
M Borges, M Lemos Pires, R Pinto, G De Sa, I Ricardo, N Cunha, et al. (+6) P Alves Da Silva, M Linan Pinto, C Sousa Guerreiro, FJ Pinto, A Abreu, H Santa-Clara |
| 77 |
[GO] |
2021―May―11 |
Physical activity and sedentary behaviour in cardiovascular disease patients during the COVID-19 lockdown in the Netherlands; a longitudinal cohort study |
BMA Van Bakel, EA Bakker, F De Vries, DHJ Thijssen, TMH Eijsvogels |
| 78 |
[GO] |
2021―May―11 |
Effects of COVID-19 lockdown on physical activity in coronary patients on a phase III cardiac rehabilitation program |
N Santaularia, A Arnau, N Tora, A Ramirez-Morros, G Vazquez-Oliva |
| 79 |
[GO] |
2021―May―11 |
During the Covid-19 lockdown, rural residence is associated to healthier lifestyle behaviours in patients with chronic coronary syndrom |
F Chague, A Cransac-Miet, M Boulin, M Saint-Jalmes, F Bichat, A Soudry, et al. (+3) N Danchin, M Zeller, Y Cottin |
| 80 |
[GO] |
2021―May―11 |
HFrEF patient activity levels during COVID-19 lockdown: A comparison between physical activity questionnaires and implantable devices data |
A Tsarouchas, C Bakogiannis, D Mouselimis, C Lazaridis, I Kelemanis, EK Theofillogiannakos, et al. (+4) ED Pagourelias, CE Papadopoulos, N Fragakis, VP Vassilikos |
| 81 |
[GO] |
2021―May―11 |
An indian clinician outlook on hypertension care during Covid-19 pandemic |
M Abhyankar, B Majumder, DK Agarwal, KA Amarnath, MUKESH Jha, BK Kumar, et al. (+3) S Revankar, SILKI Silki, VIJAY Surase |
| 82 |
[GO] |
2021―May―11 |
Impact of lockdown in patients with congestive heart failure during the Covid-19 pandemic |
F Chague, M Boulin, JC Eicher, F Bichat, M Saint-Jalmes, A Cransac-Miet, et al. (+5) A Soudry, N Danchin, G Laurent, Y Cottin, M Zeller |
| 83 |
[GO] |
2021―May―11 |
Body composition, lipid profile and mediterranean diet adherence in cardiovascular disease patients attending a long-term exercise-based cardiac rehabilitation program during COVID-19 pandemic |
M Linan Pinto, R Pinto, S Charneca, J Vasques, M Lemos Pires, M Borges, et al. (+7) C Rodrigues, P Alves Da Silva, I Ricardo, H Santa-Clara, A Abreu, FJ Pinto, C Sousa Guerreiro |
| 84 |
[GO] |
2021―May―11 |
Pulmonary embolism during the COVID-19 pandemic |
BV Silva, T Rodrigues, N Cunha, J Brito, P Alves Da Silva, P Silverio Antonio, et al. (+5) S Couto Pereira, I Aguiar Ricardo, J Rigueira, C Mendonca, A Abreu |
| 85 |
[GO] |
2021―May―11 |
Remotely monitored cardiac rehabilitation based on a walking test during the COVID-19 pandemic |
L Batalik, F Dosbaba, V Konecny, K Batalikova |
| 86 |
[GO] |
2021―May―11 |
Exercise-based cardiac rehabilitation adaptation protocol during COVID-19 pandemic achieved similar results as compared to non-pandemic usual practice: a single-center retrospective study |
AB Hartopo, ZH Islami, IA Arso, AM Ambari, B Dwiputra, B Radi |
| 87 |
[GO] |
2021―May―11 |
Web discussions on cardiovascular diseases: assessing the impact of COVID-19 pandemic. An Italian prospective analysis |
P Magni, I Cecchini, M Fortunati, M Biroli, K Massaroni, E Folco, et al. (+3) D Giudice, M Montebelli, G Ciancamerla |
| 88 |
[GO] |
2021―May―11 |
Effects of COVID-19 pandemic on physical activity: Results of the Russian online survey on spring 2020 |
A Kontsevaya, D Mukaneeva, A Myrzamatova, M Khudyakov, O Drapkina |
| 89 |
[GO] |
2021―May―11 |
COVID-19 pandemic stresses trigger ST-elevation and non-ST-elevation acute myocardial infarction in Middle Eastern individuals not infected with the virus |
A Hammoudeh, E Mdanat, R Tabbalat, M Jarrah, IA Alhaddad |
| 90 |
[GO] |
2021―May―11 |
Home-based cardiac rehabilitation during COVID-19 pandemic: effectiveness of an educational intervention |
BV Silva, I Aguiar Ricardo, P Alves Da Silva, T Rodrigues, N Cunha, S Couto Pereira, et al. (+8) P Silverio Antonio, J Brito, R Pinto, M Lemos Pires, S Fiuza, AL Correia, F J Pinto, A Abreu |
| 91 |
[GO] |
2021―May―11 |
Digital home-based multidisciplinary cardiac rehabilitation: the way to counteract physical inactivity during the COVID-19 pandemic? |
R Pinto, M Lemos Pires, M Borges, M Linan Pinto, C Sousa Guerreiro, S Miguel, et al. (+9) O Santos, M Ramalhinho, S Fiuza, M Cordeiro Ferreira, I Ricardo, N Cunha, P Alves Da Silva, FJ Pinto, A Abreu |
| 92 |
[GO] |
2021―May―11 |
ECG markers of malignant arrhythmias risk in patients with arterial hypertension hospitalized for COVID-19 pneumonia |
A Novitskiy, K Popov, A Smirnova, Y Shvarts |
| 93 |
[GO] |
2021―May―11 |
Smoking and associated unhealthy lifestyle behaviours in patients with chronic cardiac diseases during COVID-19 related lockdown |
F Chague, M Boulin, JC Eicher, F Bichat, M Saint-Jalmes, A Cransac-Miet, et al. (+6) B Trojak, A Soudry, N Danchin, G Laurent, Y Cottin, M Zeller |
| 94 |
[GO] |
2021―May―11 |
Home blood pressure during COVID-19 related lockdown in patients with hypertension |
M Pengo, F Albini, G Guglielmi, C Mollica, D Soranna, G Zambra, et al. (+3) A Zambon, G Bilo, G Parati |
| 95 |
[GO] |
2021―May―11 |
Cardiac rehabilitation and secondary prevention in COVID-19 times: Single center experience |
I Burazor, DS Spiroski, J Terzic, P Otasevic, R Babic, A Nikolic, et al. (+8) I Ilic, G Loncar, Z Cosic, M Colic, B Rihor, M Andjic, M Bojic, D Davos |
| 96 |
[GO] |
2021―May―11 |
Adherence to remote cardiac rehabilitation during the coronavirus pandemic |
I Nabutovsky, Y Klempfner, A Nachshon, S Yeshayahu, D Breitner, A Heller, R Klempfner |
| 97 |
[GO] |
2021―May―11 |
Impact of an online cardiac rehabilitation program after an acute coronary syndrome during SARS-CoV-2 pandemic |
A Severo Sanchez, B Rivero Santana, E Arbas Redondo, VM Juarez Olmos, D Poveda Pinedo, D Tebar Marquez, et al. (+2) R Dalmau Gonzalez-Galarza, A Castro Conde |
| 98 |
[GO] |
2020―Aug―06 |
CORRIGENDUM: Editor’s presentation: ‘Les liaisones dangerouses. The heart in the time of COVID-19’ |
|
| 99 |
[GO] |
2020―Jul―08 |
The morbidity and mortality of COVID-19 are associated with ABO and Rh blood groups |
Maryam Ansari-Lari, Mostafa Saadat |
| 100 |
[GO] |
2020―Jul―08 |
Obesity, overweight and survival in critically ill patients with SARS-CoV-2 pneumonia: is there an obesity paradox? Preliminary results from Italy |
Geza Halasz, Matteo LG Leoni, Giovanni Quinto Villani, Massimo Nolli, Matteo Villani |
| 101 |
[GO] |
2020―Jul―03 |
The future is now: a call for action for cardiac telerehabilitation in the COVID-19 pandemic from the secondary prevention and rehabilitation section of the European Association of Preventive Cardiology |
Martijn Scherrenberg, Matthias Wilhelm, Dominique Hansen, Heinz Völler, Véronique Cornelissen, Ines Frederix, et al. (+2) Hareld Kemps, Paul Dendale |
| 102 |
[GO] |
2020―Jun―25 |
Editor’s presentation: ‘Les liaisones dangerouses. The heart in the time of COVID-19’ |
Massimo F Piepoli |
| 103 |
[GO] |
2020―Jun―17 |
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead |
Francesco Gentile, Alberto Aimo, Francesco Forfori, Giosuè Catapano, Alberto Clemente, Filippo Cademartiri, et al. (+2) Michele Emdin, Alberto Giannoni |
| 104 |
[GO] |
2020―Jun―16 |
Sport and exercise during and beyond the COVID-19 pandemic |
Tee Joo Yeo |
| 105 |
[GO] |
2020―Jun―10 |
C3 polymorphisms represent an important immunological confounder on the spread and outcome of COVID-19 |
Xiaofeng Dai |
| 106 |
[GO] |
2020―Jun―01 |
Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC) |
Raghav T Bhatia, Sarandeep Marwaha, Aneil Malhotra, Zafar Iqbal, Christopher Hughes, Mats Börjesson, et al. (+6) Josef Niebauer, Antonio Pelliccia, Christian Schmied, Luis Serratosa, Michael Papadakis, Sanjay Sharma |
| 107 |
[GO] |
2020―May―28 |
Cardiology practice in the COVID-19 era |
Jean-Jacques Monsuez |
| 108 |
[GO] |
2020―May―28 |
C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism |
Joris R Delanghe, Marc L De Buyzere, Marijn M Speeckaert |
| 109 |
[GO] |
2020―May―28 |
Traffic-related air pollution and the coronavirus pandemia: shadows and lights |
Pier Mannuccio Mannucci |
| 110 |
[GO] |
2020―May―19 |
Physical activity/inactivity and COVID-19 |
Antonio Crisafulli, Pasquale Pagliaro |
| 111 |
[GO] |
2020―May―19 |
Comparison of cardiovascular metabolic characteristics and impact on COVID-19 and MERS |
Bo Li, Xiaodong Jin, Tongtong Zhang, Yan Zhao, Feng Tian, Yuhua Li, et al. (+3) Jing Yang, Faming Zhao, Bin Li |
| 112 |
[GO] |
2020―May―19 |
Effect of coronavirus infection on the human heart: A scoping review |
Jamie SY Ho, Paul A Tambyah, Andrew FW Ho, Mark YY Chan, Ching-Hui Sia |
| 113 |
[GO] |
2020―May―16 |
Cardiac patient care during a pandemic: how to reorganise a heart failure unit at the time of COVID-19 |
Piergiuseppe Agostoni, Massimo Mapelli, Edoardo Conte, Andrea Baggiano, Emilio Assanelli, Anna Apostolo, et al. (+11) Marina Alimento, Giovanni Berna, Marco Guglielmo, Manuela Muratori, Francesca Susini, Pietro Palermo, Beatrice Pezzuto, Elisabetta Salvioni, Anna Sudati, Carlo Vignati, Luca Merlino |
| 114 |
[GO] |
2020―May―13 |
Les liaisons dangereuses and the danger of deductions: The interplay between cardiovascular disease and COVID-19 |
Edoardo Sciatti, Claudio Ceconi |
| 115 |
[GO] |
2020―May―11 |
Cardiovascular disease and COVID-19: les liaisons dangereuses |
Andrea Barison, Alberto Aimo, Vincenzo Castiglione, Chiara Arzilli, Josep Lupón, Pau Codina, et al. (+4) Evelyn Santiago-Vacas, Germán Cediel, Michele Emdin, Antoni Bayes-Genis |
| 116 |
[GO] |
2020―Apr―28 |
ABO blood group predisposes to COVID-19 severity and cardiovascular diseases |
Xiaofeng Dai |
| 117 |
[GO] |
2020―Apr―23 |
Future-proofing cardiac rehabilitation: Transitioning services to telehealth during COVID-19 |
Emma Thomas, Robyn Gallagher, and Sherry L Grace |
| 118 |
[GO] |
2020―Apr―17 |
Cost-effectiveness of rivaroxaban plus aspirin (dual pathway inhibition) for prevention of ischaemic events in patients with cardiovascular disease: on top optimisation of secondary prevention medication in the context of COVID-19 pandemia |
Bernhard Rauch |
| 119 |
[GO] |
2020―Apr―16 |
Amiodarone as a possible therapy for coronavirus infection |
Alberto Aimo, Aldo Baritussio, Michele Emdin, Carlo Tascini |
| 120 |
[GO] |
2020―Apr―15 |
Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers |
Riccardo Sarzani, Federico Giulietti, Chiara Di Pentima, Piero Giordano, Francesco Spannella |
| 121 |
[GO] |
2020―Apr―09 |
Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19) |
Giuseppe Lippi, Brandon M Henry, Fabian Sanchis-Gomar |
| 122 |
[GO] |
2020―Apr―03 |
A dialogue between the editor-in-chief and a deputy editor of a cardiology journal during the coronavirus outbreak: Take-home messages from the Italian experience |
Massimo F Piepoli, Michele Emdin |
| 123 |
[GO] |
2020―Apr―03 |
2019 CORONAVIRUS: What are the implications for cardiology? |
R Ferrari, G Di Pasquale, C Rapezzi |
| 124 |
[GO] |
2020―Apr―01 |
Have a heart during the COVID-19 crisis: Making the case for cardiac rehabilitation in the face of an ongoing pandemic |
Tee Joo Yeo, Yi-Ting Laureen Wang, Ting Ting Low |
|
